skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis

Abstract

Abstract BACKGROUND The influence of age on balance of benefit vs. potential harm of blood pressure (BP)-lowering therapy for elderly hypertensives is unclear. We evaluated the modifying effects of age on BP lowering for various adverse outcomes in hypertensive patients older than 60 years without specified comorbidities. METHODS All relevant randomized controlled trials (RCTs) were systematically identified. Coronary heart disease, stroke, heart failure (HF), cardiovascular death, major adverse cardiovascular events (MACE), renal failure (RF), and all-cause death were assessed. Meta-regression analysis was used to explore the relationship between achieved systolic BP (SBP) and the risk of adverse events. Random-effects meta-analysis was used to pool the estimates. RESULTS Our study included 18 RCTs (n = 53,993). Meta-regression analysis showed a lower achieved SBP related with a lower risk of stroke and cardiovascular death, but an increased risk of RF. The regression slopes were comparable between populations stratifying by age 75 years. In subgroup analysis, the relative risks of a more aggressive BP lowering strategy were similar between patients aged older or less than 75 years for all outcomes except for RF (P for interaction = 0.02). Compared to treatment with final achieved SBP 140–150 mm Hg, a lower achieved SBP (<140more » mm Hg) was significantly associated with decreased risk of stroke (relative risk = 0.68; 95% confidence interval = 0.55–0.85), HF (0.77; 0.60–0.99), cardiovascular death (0.68; 0.52–0.89), and MACE (0.83; 0.69–0.99). CONCLUSIONS To treat hypertension in the elderly, age had trivial effect modification on most outcomes, except for renal failure. Close monitoring of renal function may be warranted in the management of elderly hypertension.« less

Authors:
 [1];  [2];  [3];  [4];  [5];  [6];  [7]; ORCiD logo [8]
  1. Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  2. General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan
  3. Institute of Cardiovascular Sciences, University College London (UCL) and National Institute for Health Research (NIHR) UCL Hospitals Biomedical Research Centre, London, UK
  4. Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan
  5. Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Department of Medicine, National Yang-Ming University, Taipei, Taiwan
  6. Department of Medicine, National Yang-Ming University, Taipei, Taiwan, Division of Faculty Development, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University, Taipei, Taiwan
  7. Division of Cardiology, National Taiwan University Hospital, Taipei, Taiwan
  8. Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Department of Medicine, National Yang-Ming University, Taipei, Taiwan, Division of Faculty Development, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University, Taipei, Taiwan
Publication Date:
Sponsoring Org.:
USDOE Office of Electricity Delivery and Energy Reliability (OE), Power Systems Engineering Research and Development (R&D) (OE-10)
OSTI Identifier:
1490896
Alternate Identifier(s):
OSTI ID: 1485519
Grant/Contract Number:  
NO1-AG-1-2118
Resource Type:
Published Article
Journal Name:
American Journal of Hypertension
Additional Journal Information:
Journal Name: American Journal of Hypertension Journal Volume: 32 Journal Issue: 2; Journal ID: ISSN 0895-7061
Publisher:
Oxford University Press
Country of Publication:
United States
Language:
English

Citation Formats

Huang, Chi-Jung, Chiang, Chern-En, Williams, Bryan, Kario, Kazuomi, Sung, Shih-Hsien, Chen, Chen-Huan, Wang, Tzung-Dau, and Cheng, Hao-Min. Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis. United States: N. p., 2018. Web. doi:10.1093/ajh/hpy169.
Huang, Chi-Jung, Chiang, Chern-En, Williams, Bryan, Kario, Kazuomi, Sung, Shih-Hsien, Chen, Chen-Huan, Wang, Tzung-Dau, & Cheng, Hao-Min. Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis. United States. doi:https://doi.org/10.1093/ajh/hpy169
Huang, Chi-Jung, Chiang, Chern-En, Williams, Bryan, Kario, Kazuomi, Sung, Shih-Hsien, Chen, Chen-Huan, Wang, Tzung-Dau, and Cheng, Hao-Min. Fri . "Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis". United States. doi:https://doi.org/10.1093/ajh/hpy169.
@article{osti_1490896,
title = {Effect Modification by Age on the Benefit or Harm of Antihypertensive Treatment for Elderly Hypertensives: A Systematic Review and Meta-analysis},
author = {Huang, Chi-Jung and Chiang, Chern-En and Williams, Bryan and Kario, Kazuomi and Sung, Shih-Hsien and Chen, Chen-Huan and Wang, Tzung-Dau and Cheng, Hao-Min},
abstractNote = {Abstract BACKGROUND The influence of age on balance of benefit vs. potential harm of blood pressure (BP)-lowering therapy for elderly hypertensives is unclear. We evaluated the modifying effects of age on BP lowering for various adverse outcomes in hypertensive patients older than 60 years without specified comorbidities. METHODS All relevant randomized controlled trials (RCTs) were systematically identified. Coronary heart disease, stroke, heart failure (HF), cardiovascular death, major adverse cardiovascular events (MACE), renal failure (RF), and all-cause death were assessed. Meta-regression analysis was used to explore the relationship between achieved systolic BP (SBP) and the risk of adverse events. Random-effects meta-analysis was used to pool the estimates. RESULTS Our study included 18 RCTs (n = 53,993). Meta-regression analysis showed a lower achieved SBP related with a lower risk of stroke and cardiovascular death, but an increased risk of RF. The regression slopes were comparable between populations stratifying by age 75 years. In subgroup analysis, the relative risks of a more aggressive BP lowering strategy were similar between patients aged older or less than 75 years for all outcomes except for RF (P for interaction = 0.02). Compared to treatment with final achieved SBP 140–150 mm Hg, a lower achieved SBP (<140 mm Hg) was significantly associated with decreased risk of stroke (relative risk = 0.68; 95% confidence interval = 0.55–0.85), HF (0.77; 0.60–0.99), cardiovascular death (0.68; 0.52–0.89), and MACE (0.83; 0.69–0.99). CONCLUSIONS To treat hypertension in the elderly, age had trivial effect modification on most outcomes, except for renal failure. Close monitoring of renal function may be warranted in the management of elderly hypertension.},
doi = {10.1093/ajh/hpy169},
journal = {American Journal of Hypertension},
number = 2,
volume = 32,
place = {United States},
year = {2018},
month = {11}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
DOI: https://doi.org/10.1093/ajh/hpy169

Citation Metrics:
Cited by: 1 work
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Bias in meta-analysis detected by a simple, graphical test
journal, September 1997


Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
journal, January 1998


Systolic Blood Pressure Trajectory, Frailty, and All-Cause Mortality >80 Years of Age: Cohort Study Using Electronic Health Records
journal, June 2017


Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
journal, March 2017


Dementia and Disability Outcomes in Large Hypertension Trials: Lessons Learned from the Systolic Hypertension in the Elderly Program (SHEP) Trial
journal, January 2001

  • Di Bari, Mauro; Pahor, Marco; Franse, Lonneke V.
  • American Journal of Epidemiology, Vol. 153, Issue 1
  • DOI: 10.1093/aje/153.1.72

Impact of amlodipine-based therapy among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial−Blood Pressure Lowering Arm (ASCOT-BPLA)
journal, January 2011


Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
journal, November 1991


Randomised trial of treatment of hypertension in elderly patients in primary care.
journal, November 1986


The predictive ability of blood pressure in elderly trial patients
journal, January 2012


Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
journal, October 1998


Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension
journal, July 1997


The effect of antihypertensive treatment on the incidence of stroke and cognitive decline in the elderly: a meta-analysis
journal, March 2016

  • Parsons, Christine; Murad, Mohammad Hassan; Andersen, Stuart
  • Future Cardiology, Vol. 12, Issue 2
  • DOI: 10.2217/fca.15.90

Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older: A Systematic Review and Meta-analysis
journal, January 2017

  • Weiss, Jessica; Freeman, Michele; Low, Allison
  • Annals of Internal Medicine, Vol. 166, Issue 6
  • DOI: 10.7326/M16-1754

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
journal, May 2018

  • Whelton, Paul K.; Carey, Robert M.; Aronow, Wilbert S.
  • Journal of the American College of Cardiology, Vol. 71, Issue 19
  • DOI: 10.1016/j.jacc.2017.11.006

Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study.
journal, January 1989


The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial
journal, January 2003


Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial
journal, June 2016

  • Williamson, Jeff D.; Supiano, Mark A.; Applegate, William B.
  • JAMA, Vol. 315, Issue 24
  • DOI: 10.1001/jama.2016.7050

Shanghai trial of nifedipine in the elderly
journal, January 1996


Chinese Trial on Isolated Systolic Hypertension in the Elderly
journal, January 2000


Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients
journal, February 2017

  • Bavishi, Chirag; Bangalore, Sripal; Messerli, Franz H.
  • Journal of the American College of Cardiology, Vol. 69, Issue 5
  • DOI: 10.1016/j.jacc.2016.10.077

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
journal, September 1997


Results of the pilot study for the Hypertension in the Very Elderly Trial
journal, January 2003


Effects of Intensive Antihypertensive Treatment on Chinese Hypertensive Patients Older Than 70 Years
journal, April 2013

  • Wei, Yong; Jin, Zhimin; Shen, Guoying
  • The Journal of Clinical Hypertension, Vol. 15, Issue 6
  • DOI: 10.1111/jch.12094

The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients
journal, March 2005


Treatment of Hypertension in Patients 80 Years of Age or Older
journal, May 2008

  • Beckett, Nigel S.; Peters, Ruth; Fletcher, Astrid E.
  • New England Journal of Medicine, Vol. 358, Issue 18
  • DOI: 10.1056/NEJMoa0801369

A basic introduction to fixed-effect and random-effects models for meta-analysis
journal, April 2010

  • Borenstein, Michael; Hedges, Larry V.; Higgins, Julian P. T.
  • Research Synthesis Methods, Vol. 1, Issue 2
  • DOI: 10.1002/jrsm.12